Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
PUT
Celsius Holdings
CELH
$7.47B
| $4.65M | ﹤0.01% |
150,000
-208,500
| -58% | -$6.58M |
|
|
ATEK
1577
DELISTED
Athena Technology Acquisition Corp. II
ATEK
| $4.65M | ﹤0.01% |
452,452
| – | – |
|
1578
CALL
Range Resources
RRC
$9.38B
| $4.63M | ﹤0.01% |
175,000
-453,200
| -72% | -$11.4M |
|
1579
Urban Edge Properties
UE
$2.86B
| $4.62M | ﹤0.01% |
306,815
-236,637
| -44% | -$3.56M |
|
|
NUVA
1580
DELISTED
NuVasive, Inc.
NUVA
| $4.61M | ﹤0.01% |
111,652
+24,103
| +28% | +$1.03M |
|
1581
PUT
Chewy
CHWY
$9.25B
| $4.61M | ﹤0.01% |
123,200
-243,500
| -66% | -$10.1M |
|
1582
RLI Corp
RLI
$5.62B
| $4.6M | ﹤0.01% |
69,198
+19,476
| +39% | +$1.29M |
|
1583
Academy Sports + Outdoors
ASO
$2.94B
| $4.6M | ﹤0.01% |
70,443
+31,229
| +80% | +$1.84M |
|
1584
Royal Gold
RGLD
$16.8B
| $4.59M | ﹤0.01% |
35,359
+15,790
| +81% | +$1.95M |
|
|
GTY
1585
Getty Realty Corp
GTY
$2.11B
| $4.58M | ﹤0.01% |
127,030
-50,871
| -29% | -$1.78M |
|
1586
CareTrust REIT
CTRE
$9.91B
| $4.57M | ﹤0.01% |
233,317
-141,377
| -38% | -$2.77M |
|
|
FNVT
1587
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
| $4.56M | ﹤0.01% |
437,061
| – | – |
|
|
BPMC
1588
DELISTED
Blueprint Medicines
BPMC
| $4.56M | ﹤0.01% |
101,400
-22,786
| -18% | -$1.03M |
|
1589
Travere Therapeutics
TVTX
$5.2B
| $4.56M | ﹤0.01% |
202,786
+18,000
| +10% | +$383K |
|
|
PRFT
1590
DELISTED
Perficient Inc
PRFT
| $4.55M | ﹤0.01% |
63,097
-193
| -0.3% | -$14.1K |
|
1591
iShares MSCI Australia ETF
EWA
$1.39B
| $4.54M | ﹤0.01% |
198,110
+125,537
| +173% | +$2.94M |
|
1592
United Bankshares
UBSI
$6.63B
| $4.54M | ﹤0.01% |
128,842
+59,263
| +85% | +$2.33M |
|
1593
PUT
CRISPR Therapeutics
CRSP
$4.73B
| $4.52M | ﹤0.01% |
100,000
+33,400
| +50% | +$1.62M |
|
1594
Woodward
WWD
$21.3B
| $4.52M | ﹤0.01% |
46,449
+20,906
| +82% | +$2.1M |
|
1595
CVR Energy
CVI
$3.58B
| $4.51M | ﹤0.01% |
137,587
+128,731
| +1,454% | +$4.13M |
|
1596
CALL
UiPath
PATH
$6.61B
| $4.51M | ﹤0.01% |
+256,700
| New | +$3.88M |
|
1597
Home BancShares
HOMB
$6.23B
| $4.48M | ﹤0.01% |
206,507
+80,777
| +64% | +$1.86M |
|
1598
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
| $4.48M | ﹤0.01% |
60,000
-65,200
| -52% | -$4.77M |
|
1599
Western Alliance Bancorporation
WAL
$8.79B
| $4.47M | ﹤0.01% |
125,814
+80,187
| +176% | +$4.91M |
|
1600
Allison Transmission
ALSN
$9.5B
| $4.46M | ﹤0.01% |
98,498
-14,612
| -13% | -$656K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.